Independent investment bank and asset management firm Needham & Company, which specializes in financings for growth companies, has set a ‘buy’ rating for Cardlytics (NASDAQ: CDLX) despite the stoc...
Independent investment bank and asset management firm Needham & Company, which specializes in financings for growth companies, has set a ‘buy’ rating for Cardlytics (NASDAQ: CDLX) despite the stoc...